[PLX] YoY Quarter Result on 31-Mar-2010 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-May-2010
Financial Year
2010
Quarter
31-Mar-2010 [#Q1]
Profit Trend
QoQ- 46.74%
YoY- -53.48%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 3,968 3,728 6,000 1,141 0 0 0 -
PBT -4,321 0 -5,052 -7,955 0 -1,150 -331 53.38%
Tax 0 -161 0 0 148 -1,150 3,119 -
NP -4,321 -5,904 -5,052 -7,955 -5,183 -5,113 -3,450 3.81%
Tax Rate - - - - - - - -
Total Cost 8,289 9,632 11,052 9,096 5,183 5,113 3,450 15.71%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin -108.90 -158.37 -84.20 -697.20 0.00 0.00 0.00 -
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
EPS -0.05 -0.07 -0.06 -0.10 -0.07 -0.07 -0.54 -32.71%
EPS Diluted -0.05 -0.07 -0.06 -0.10 -0.07 -0.07 -0.54 -32.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.